SHA:600789 Revenue

Shandong Lukang Pharmaceutical had revenue of 1.67B CNY in the quarter ending March 31, 2025, a decrease of -6.95%. This brings the company's revenue in the last twelve months to 6.11B, down -2.67% year-over-year. In the year 2024, Shandong Lukang Pharmaceutical had annual revenue of 6.23B with 1.41% growth.

Revenue (ttm)

6.11B

Revenue Growth

-2.67%

P/S Ratio

1.59

Revenue / Employee

956.18K

Employees

6,484

Market Cap

9.74B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.23B	86.37M	1.41%
Dec 31, 2023	6.15B	525.28M	9.34%
Dec 31, 2022	5.62B	697.66M	14.17%
Dec 31, 2021	4.92B	718.67M	17.09%
Dec 31, 2020	4.21B	472.39M	12.66%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Shanghai United Imaging Healthcare	10.43B
Sichuan Biokin Pharmaceutical	5.82B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings